Work

1415 Confirmation That Quadruple Therapy With Daclatasvir (ns5a Inhibitor), Asunaprevir (ns3 Inhibitor) and Peginterferon/ribavirin Results in High Rate of Svr4 in Hcv Genotype 1 Null Responders